Skip to main content

CITADEL ADVISORS LLC

Position in ELDN — Eledon Pharmaceuticals, Inc.

CIK 1423053 MIAMI, FL

Position in ELDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$850,933
+$850,933 QoQ
Shares Held
215,973
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#32
of 159 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ELDN Over Time

Shares Held

Position Value (USD)

Derivatives in ELDN

reported options exposure · as of Jun 30, 2026
CallValue
$60,282
CallShares
15,300
PutValue
$1,100,836
PutShares
279,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,670,159 across 436 Biotechnology names. ELDN ranks #239 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ELDN

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,100,836 279,400
2026-06-30 $850,933 215,973
2026-06-30 $60,282 15,300
2026-03-31 $138,600 45,000
2025-12-31 $75,198 49,800
2025-12-31 $45,753 30,300
2025-09-30 $86,506 33,400
2025-06-30 $413,166 152,460
2025-06-30 $82,113 30,300
2025-03-31 $155,262 45,800
2025-03-31 $318,649 93,997
2025-03-31 $35,595 10,500
2024-12-31 $11,124 2,700
2024-12-31 $70,040 17,000
2024-12-31 $782,264 189,870
2024-03-31 $2,884 1,400
2024-03-31 $32,922 15,982
2024-03-31 $1,030 500
2023-12-31 $720 400
2023-12-31 $41,774 23,208
2023-06-30 $6,302 4,600
2023-06-30 $10,603 7,740
2023-03-31 $3,304 1,400
2023-03-31 $72,711 30,810
2023-03-31 $13,924 5,900
2022-06-30 $48,800 20,000
2022-03-31 $68,950 17,500
2021-12-31 $44,867 10,174
2021-09-30 $79,722 12,900
2021-03-31 $268,163 25,062